Rein Therapeutics, Inc. (RNTX): auditor change — Rein Therapeutics auditor Marcum resigns, CBIZ appointed; going concern noted

Rein Therapeutics, Inc.

Marcum LLP resigned as independent auditor on April 16, 2025; CBIZ CPAs P.C. engaged by Audit Committee.
Marcum's reports for 2024 and 2023 included a going concern explanatory paragraph for Rein Therapeutics.
No disagreements on accounting principles or practices between Marcum and the company.
Material weaknesses in internal controls over financial reporting were reported for both 2024 and 2023.
Company authorized Marcum to fully respond to successor auditor inquiries.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Marcum LLP resigned as auditor of Rein Therapeutics, Inc..

Action: resignation
Auditor: Marcum LLP
Successor: CBIZ CPAs P.C.

Exact text from the filing

Marcum had resigned as the Company’s independent registered public accounting firm, effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Rein Therapeutics, Inc. engaged CBIZ CPAs P.C. as its auditor.

Action: engagement
Auditor: CBIZ CPAs P.C.

Exact text from the filing

On November 1, 2024, CBIZ CPAs P.C. (“CBIZ CPAs”) acquired the attest business of Marcum. On April 16, 2025, following the approval of the Audit Committee of the Board of Directors of the Company, CBIZ CPAs was engaged, effective immediately.

View on SEC.gov

Browse all auditor changes →

Rein Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-084340

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.